arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Definium Therapeutics, Inc.

DFTX Health Care Medicinal Chemicals and Botanical Products
$37.98
▼ -0.3% Today
as of Sep 4, 16:48 ET
Last 30 days -9.22% Jul 28 → Sep 04
$37.35 $39.72 $42.09 $44.46 $46.83 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$37.94
High
$38.54
Low
$37.50
Volume
$1M
Avg Vol
$2M
Mkt Cap
$5.0B
P/E (TTM)
—
Beta
—
52w High
$49.70
52w Low
$8.77
Div Yield
—
Shares Out
$134M

Recent Press Releases & News last 60 days · 25 items

Aug 31 · 20:01 PR Business Wire
Definium Therapeutics Announces New Employee Inducement Grants
Aug 26 · 11:01 PR Business Wire
Definium Therapeutics to Participate at Upcoming Investor Conferences and Events
Aug 17 · 20:01 PR Business Wire
Definium Therapeutics Announces New Employee Inducement Grants
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$8.77
$50
71% of range
Avg surprise (last 3)
-26.6%
Avg reaction (last 2)
-1.5%
0% positive
Latest IV / EM
111%
EM ±17.3% · $38 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.44$-1.15$-0.85$-0.55$-0.26 Actual $-0.65Actual $-0.76Actual $-0.45Actual $-1.14Actual $-0.26Actual $-0.27Actual $-0.35Est $-0.36Actual $-0.50Est $-0.38Actual $-0.78Actual $-0.71Est $-0.47Actual $-1.44 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-159M$-123M$-87M$-51M$-14M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.44 — — — — financials
Thu May 7, 2026Mar/2026 $-0.71 $-0.47 -51.1% -102.9% -0.9% earnings
Tue Sep 30, 2025Sep 2025 $-0.78 — — — — financials
Thu Jul 31, 2025Jun/2025 $-0.50 $-0.38 -31.6% — — earnings
Thu May 8, 2025Mar/2025 $-0.35 $-0.36 +2.8% — -2.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.27 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.26 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.14 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.45 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.76 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.65 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-75M$-59M—$-46M$-41M$-32M—$-25M
Net income$-159M$-77M—$-67M$-43M$-23M—$-14M
EPS (diluted)$-1.44$-0.71—$-0.78$-0.50$-0.35—$-0.27

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$655M$263M$258M$20M$33M$83M$274M$295M
Inventory————————
Total current assets$1.09B$381M$419M$216M$189M$222M$282M$299M
Total assets$1.11B$401M$440M$237M$265M$275M$302M$320M
Long-term debt$36M$41M—$40M$41M$22M—$24M
Total liabilities$194M$122M$108M$106M$80M$53M$61M$58M
Total equity$919M$279M$332M$131M$185M$223M$241M$262M

Implied volatility — last 90 days

67%105%143%181%219% Jun 07 — IV 150% · EM ±20.8%Jun 08 — IV 155% · EM ±20.5%Jun 09 — IV 123% · EM ±15.5%Jun 10 — IV 121% · EM ±14.3%Jun 11 — IV 118% · EM ±13.1%Jun 12 — IV 102% · EM ±10.5%Jun 15 — IV 139% · EM ±10.1%Jun 16 — IV 145% · EM ±8.6%Jun 17 — IV 181% · EM ±7.6%Jun 19 — IV 137% · EM ±30.2%Jun 22 — IV 81% · EM ±16.9%Jun 23 — IV 68% · EM ±13.8%Jun 24 — IV 77% · EM ±15.3%Jun 25 — IV 72% · EM ±14.0%Jun 26 — IV 76% · EM ±14.5%Jun 29 — IV 73% · EM ±13.0%Jun 30 — IV 72% · EM ±12.4%Jul 01 — IV 72% · EM ±12.0%Jul 02 — IV 70% · EM ±11.3%Jul 03 — IV 72% · EM ±11.3%Jul 06 — IV 72% · EM ±10.0%Jul 07 — IV 73% · EM ±9.6%Jul 08 — IV 78% · EM ±9.7%Jul 09 — IV 70% · EM ±8.3%Jul 10 — IV 104% · EM ±11.5%Jul 13 — IV 114% · EM ±9.5%Jul 14 — IV 107% · EM ±7.8%Jul 15 — IV 93% · EM ±5.5%Jul 16 — IV 113% · EM ±4.7%Jul 20 — IV 125% · EM ±29.5%Jul 21 — IV 115% · EM ±26.8%Jul 22 — IV 123% · EM ±28.1%Jul 23 — IV 116% · EM ±26.2%Jul 24 — IV 110% · EM ±24.3%Jul 27 — IV 117% · EM ±24.4%Jul 28 — IV 113% · EM ±23.1%Jul 29 — IV 118% · EM ±23.6%Jul 30 — IV 112% · EM ±21.9%Jul 31 — IV 120% · EM ±23.1%Aug 03 — IV 119% · EM ±21.1%Aug 04 — IV 121% · EM ±20.8%Aug 05 — IV 145% · EM ±24.3%Aug 06 — IV 151% · EM ±24.3%Aug 07 — IV 171% · EM ±26.7%Aug 10 — IV 182% · EM ±25.2%Aug 11 — IV 220% · EM ±29.0%Aug 12 — IV 91% · EM ±11.4%Aug 13 — IV 83% · EM ±9.8%Aug 14 — IV 80% · EM ±8.8%Aug 17 — IV 97% · EM ±8.1%Aug 18 — IV 94% · EM ±6.8%Aug 19 — IV 115% · EM ±6.8%Aug 20 — IV 79% · EM ±3.3%Aug 24 — IV 96% · EM ±20.0%Aug 25 — IV 85% · EM ±17.4%Aug 26 — IV 92% · EM ±18.4%Aug 27 — IV 87% · EM ±17.1%Aug 28 — IV 82% · EM ±15.6%Aug 31 — IV 98% · EM ±17.4%Sep 01 — IV 115% · EM ±19.7%Sep 02 — IV 108% · EM ±18.0%Sep 03 — IV 112% · EM ±18.1%Sep 04 — IV 111% · EM ±17.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in